{
  "actions": [
    {
      "acted_at": "2011-02-16", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2011-02-28", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr741-112", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "112", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2011-02-16", 
  "number": "741", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s373-112", 
      "reason": "related"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "district": "8", 
    "name": "Emerson, Jo Ann", 
    "state": "MO", 
    "thomas_id": "01481", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2011-02-16", 
  "subjects": [
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2011-02-16", 
    "text": "Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T21:59:21-05:00"
}